Thanks CytoDyn for the Letter to Shareholders. We need to know what's happening to stop speculation here. I don''t see any way around the enrollment problem except with hooking up with Big Pharma. They have the reps, the money, etc. and they don't care if they get spanked for hype about their drugs. The squeaky gear gets the oil theory.

I would like to see one person whose job it is get us deals, nothing else. The success of Leronlimab in the clinic and the success of getting Leronlimab into the clinic are two completely different games. The goal should be to make them one game.